Zobrazeno 1 - 10 of 457 pro vyhledávání: '"Dakin L"'
2
Akademický článek
Using the Theoretical Domains Framework to Identify Barriers and Facilitators to Elder-Friendly Care Implementation Within a Multi-Site Academic Health Centre.
Autor: Dakin L; McGill University Health Centre (MUHC), Montréal, QC, Canada., Valdron-Nguyen S; McGill University Health Centre (MUHC), Montréal, QC, Canada., Castiglione S; McGill University Health Centre (MUHC), Montréal, QC, Canada., Briand A; McGill University Health Centre (MUHC), Montréal, QC, Canada., Oliver C; McGill University Health Centre (MUHC), Montréal, QC, Canada., Kusaian T; McGill University Health Centre (MUHC), Montréal, QC, Canada.
Publikováno v: Worldviews on evidence-based nursing [Worldviews Evid Based Nurs] 2021 Oct; Vol. 18 (5), pp. 310-313. Date of Electronic Publication: 2021 May 20.
Zobrazit plný text záznamu
3
Akademický článek
Development and validation of an aetiology in delirium diagnostic support tool.
Autor: Eeles E; Internal Medicine Services, The Prince Charles Hospital, Brisbane, Queensland, Australia.; Northside Clinical School, School of Medicine, University of Queensland, Brisbane, Australia.; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Huang L; Department of Medicine, Logan Hospital, Brisbane, Queensland, Australia., Dakin L; Internal Medicine Services, The Prince Charles Hospital, Brisbane, Queensland, Australia.; Northside Clinical School, School of Medicine, University of Queensland, Brisbane, Australia., Ling C; Internal Medicine Services, The Prince Charles Hospital, Brisbane, Queensland, Australia.; Northside Clinical School, School of Medicine, University of Queensland, Brisbane, Australia., Dunn E; Allied Health, The Prince Charles Hospital, Brisbane, Queensland, Australia., Fraser J; Metro North IT, The Prince Charles Hospital, Brisbane, Queensland, Australia., Dissanayaka NN; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Neurology, Royal Brisbane & Women's Hospital, Herston Queensland, Australia.; School of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
Publikováno v: Age and ageing [Age Ageing] 2021 Jun 28; Vol. 50 (4), pp. 1402-1405.
Zobrazit plný text záznamu
4
Akademický článek
Heteroarylamide smoothened inhibitors: Discovery of N-[2,4-dimethyl-5-(1-methylimidazol-4-yl)phenyl]-4-(2-pyridylmethoxy)benzamide (AZD8542) and N-[5-(1H-imidazol-2-yl)-2,4-dimethyl-phenyl]-4-(2- pyridylmethoxy)benzamide (AZD7254).
Autor: Yang B; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA. Electronic address: byang@kymeratx.com., Hird AW; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Bodnarchuk MS; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Building 310, Cambridge Science Park, Milton Road, Cambridge, UK., Zheng X; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Dakin L; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Su Q; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Daly K; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Godin R; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Hattersley MM; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Brassil P; Drug Metabolism and Pharmacokinetics, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Redmond S; Oncology Safety, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., John Russell D; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA., Janetka JW; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA.
Publikováno v: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2020 Jan 15; Vol. 28 (2), pp. 115227. Date of Electronic Publication: 2019 Dec 11.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay.
Autor: Hall J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Brault A; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Vincent F; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Weng S; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America., Wang H; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Dumlao D; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Aulabaugh A; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Aivazian D; Pfizer Centers for Therapeutic Innovation (CTI), San Diego, California, United States of America., Castro D; Pfizer Centers for Therapeutic Innovation (CTI), San Diego, California, United States of America., Chen M; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Culp J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Dower K; Inflammation and Immunology, Pfizer, Cambridge, Massachusetts, United States of America., Gardner J; External Research Solutions, Pfizer, Groton, Connecticut, United States of America., Hawrylik S; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Golenbock D; University of Massachusetts Medical School, Worcester, Massachusetts, United States of America., Hepworth D; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Horn M; Pfizer Centers for Therapeutic Innovation (CTI), San Diego, California, United States of America., Jones L; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Jones P; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Latz E; University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.; Institute of Innate Immunity, University Hospitals Bonn, Bonn, Germany., Li J; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Lin LL; Inflammation and Immunology, Pfizer, Cambridge, Massachusetts, United States of America., Lin W; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Lin D; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Lovering F; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Niljanskul N; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Nistler R; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America., Pierce B; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Plotnikova O; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Schmitt D; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Shanker S; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Smith J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Snyder W; Pfizer Centers for Therapeutic Innovation (CTI), San Diego, California, United States of America., Subashi T; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Trujillo J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Tyminski E; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America., Wang G; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America., Wong J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Lefker B; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Dakin L; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Leach K; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America.
Publikováno v: PloS one [PLoS One] 2017 Sep 21; Vol. 12 (9), pp. e0184843. Date of Electronic Publication: 2017 Sep 21 (Print Publication: 2017).
Zobrazit plný text záznamu
7
Akademický článek
Reliability of an Online Geriatric Assessment Procedure Using the interRAI Acute Care Assessment System.
Autor: Martin-Khan MG; Centre for Research in Geriatric Medicine, University of Queensland, Woolloongabba, Queensland, Australia.; Centre for Online Health, The University of Queensland, Woolloongabba, Queensland, Australia., Edwards H; Faculty of Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia., Wootton R; The University of Queensland, Woolloongabba, Queensland, Australia., Counsell SR; Center for Aging Research and Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, United States of America., Varghese P; Princess Alexandra Hospital, Queensland Health, Woolloongabba, Brisbane, Queensland, Australia., Lim WK; @Age, Melbourne Health, University of Melbourne, Melbourne, Victoria, Australia.; Clinical Research Centre, Northern Health, Epping, Victoria, Australia., Darzins P; Eastern Health Clinical School, Eastern Health, Box Hill, Victoria, Australia.; Geriatric Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia., Dakin L; Ipswich Hospital, West Moreton Hospital and Health Service, Ipswich, Queensland, Australia., Klein K; Clinical Trials and Biostatistics Centre, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Gray LC; Centre for Research in Geriatric Medicine, University of Queensland, Woolloongabba, Queensland, Australia.; Centre for Online Health, The University of Queensland, Woolloongabba, Queensland, Australia.
Publikováno v: Journal of the American Geriatrics Society [J Am Geriatr Soc] 2017 Sep; Vol. 65 (9), pp. 2029-2036. Date of Electronic Publication: 2017 Aug 21.
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Biomimetic Exogenous "Tissue Batteries" as Artificial Power Sources for Implantable Bioelectronic Devices Manufacturing.
Autor: Yue, Ouyang1,2 (AUTHOR), Wang, Xuechuan1,3 (AUTHOR) wangxc@sust.edu.cn, Xie, Long1,3 (AUTHOR), Bai, Zhongxue1,2 (AUTHOR), Zou, Xiaoliang1,2 (AUTHOR), Liu, Xinhua1,2 (AUTHOR) liuxinhua@sust.edu.cn
Publikováno v: Advanced Science. 3/20/2024, Vol. 11 Issue 11, p1-42. 42p.
Zobrazit plný text záznamu
10
Akademický článek
Astrocytic accumulation of tau fibrils isolated from Alzheimer's disease brains induces inflammation, cell-to-cell propagation and neuronal impairment.
Autor: Eltom, Khalid1 (AUTHOR), Mothes, Tobias1 (AUTHOR), Libard, Sylwia2,3 (AUTHOR), Ingelsson, Martin1,4,5 (AUTHOR), Erlandsson, Anna1 (AUTHOR) anna.erlandsson@pubcare.uu.se
Publikováno v: Acta Neuropathologica Communications. 2/26/2024, Vol. 12 Issue 1, p1-16. 16p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje